Clinical and Pathological Characteristics of Women With Ovarian Cancers in Syria
NCT06253559 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 531
Last updated 2024-02-15
Summary
the goal of this observational study is to describe ovarian cancer epidemiology and characteristics in Syrian women, especially during the war to do more research in the future about the risk factors of ovarian cancer.
Conditions
Sponsors & Collaborators
-
Tishreen University
lead OTHER
Principal Investigators
-
Apelian · Tishreen University
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2021-07-31
- Completion
- 2023-12-24
Countries
- Syria
Study Locations
More Related Trials
-
Search for Predictors of Therapeutic Response in Ovarian Carcinoma
NCT01391351 ·Status: COMPLETED ·Phase: NA
-
Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer
NCT00452985 ·Status: COMPLETED
-
Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve
NCT00712452 ·Status: TERMINATED ·Phase: NA
-
Pathway to Diagnosis of Ovarian Cancer
NCT01061619 ·Status: UNKNOWN
-
Ovarian Reserve After Cancer: Longitudinal Effects
NCT02467231 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer
NCT00772863 ·Status: COMPLETED ·Phase: PHASE2
-
Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs.
NCT02323568 ·Status: COMPLETED ·Phase: NA
-
Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma
NCT02297958 ·Status: COMPLETED
-
Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer
NCT04752865 ·Status: UNKNOWN
-
Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response
NCT03831230 ·Status: COMPLETED
-
Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer
NCT01809379 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer
NCT06775470 ·Status: RECRUITING
-
Experience in Borderline Ovarian Tumors
NCT05791838 ·Status: UNKNOWN
-
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response
NCT00103545 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
NCT00043472 ·Status: COMPLETED
-
Risk of Ovarian Cancer in Patients With a Pelvic Mass
NCT00315692 ·Status: COMPLETED
-
Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
NCT06800105 ·Status: RECRUITING
-
Ovarian Tumor Biopsies to Study Response to Treatments
NCT02952521 ·Status: COMPLETED
-
Thiol-disulfide Homeostasis in Patients With Ovarian Cancer
NCT05011539 ·Status: COMPLETED
-
Tumor Gene Expression in Women With Ovarian Cancer
NCT00817479 ·Status: COMPLETED ·Phase: PHASE4
-
Oxford Ovarian Cancer Predict Chemotherapy Response 01
NCT01770535 ·Status: UNKNOWN
-
Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer
NCT03611179 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer
NCT06907771 ·Status: RECRUITING
-
Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer
NCT02408536 ·Status: UNKNOWN
-
Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases
NCT01048814 ·Status: COMPLETED